The BioMedical group of VRV S.p.A has appointed Steven T. Shaw as its new President.
Shaw has been serving as President of the BioMedical group at Chart Industries Inc. for the past 15 years and will bring a wealth of experience to the Italian outfit.
Under his new role, Shaw (left) will be responsible for building upon the company’s current product platform by offering specifically-tailored products to regulatory and application requirements of breakout global markets such as cell therapy and biobanking.
VRV’s BioMedical group includes its Cryo Diffusion subsidiary, a leading supplier of products for the long-term cryogenic storage of biological materials.
Shaw’s new business unit intends to transform the 50 years of excellence that Cryo Diffusion holds in the cryogenic storage space, as well home oxygen therapy systems, with tailored product offerings for new applications and geographies.
Shaw enthused about his new post, stating, “I am truly excited to take on the project of transforming Cryo Diffusion into a leading global brand by leveraging the quality, technical expertise and supply chain of the global VRV group in combination with the world-leading skills and expertise of my team.”